Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases

Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases
复制标题

DOI:
10.1006/jaut.2002.0622
复制
发表时间:
2002-12-01
影响因子:
12.8
通讯作者:
Mackay, IR
Mackay, IR
中科院分区:
医学1区
文献类型:
--
作者:
Fida, S;Myers, MA;Mackay, IR

文献摘要

被引文献

相似文献

SOX 13分子最初被鉴定为1型糖尿病中的自身抗原(ICA 12)。SOX 13是SOX家族转录调节蛋白的成员,其含有与HMG蛋白1和2具有结构相似性的高迁移率族(HMG)基序。HMG 1和2的抗体出现在肝脏的自身免疫性疾病和溃疡性结肠炎中。我们通过放射免疫沉淀法测定了原发性胆汁性肝硬化(PBQ)和其他疾病中抗SOX 13的发生率和水平,并与ELISA法测定的抗HMG的频率进行了比较。在PBC患者中检测到18%的抗-SOX 13,13%的自身免疫性肝炎,18%的1型糖尿病,在其他疾病中的频率较低,包括多系统自身免疫性疾病,系统性红斑狼疮和类风湿性关节炎,并在1%的正常血清。抗HMG 1和抗HMG 2在PBC中的检出率分别为30%和35%。血清抗SOX 13和抗HMG水平与PBC显著相关,但与1型糖尿病无关。PBC中的抗SOX 13可能仅仅作为对实质组织损伤产物的免疫应答而发生,或者可能说明转录调节蛋白引起自身免疫应答的一般倾向。(C)2002爱思唯尔科技有限公司版权所有。
The molecule SOX13 was initially identified as an autoantigen (ICA12) in Type 1 diabetes. SOX13 is a member of the SOX family of transcriptional regulatory proteins that contain a high mobility group (HMG) motif with structural similarity to HMG proteins 1 and 2. Antibodies to HMG 1 and 2 occur in autoimmune diseases of the liver and in ulcerative colitis. We measured the occurrence and levels of anti-SOX13 by radioimmunoprecipitation in primary biliary cirrhosis (PBQ and other diseases, and compared frequencies with anti-HMG measured by ELISA. Anti-SOX13 was detected in 18% of patients with PBC, 13% with autoimmune hepatitis, 18% with Type 1 diabetes, at lower frequencies in other conditions including the multisystem autoimmune diseases, systemic lupus erythematosus and rheumatoid arthritis, and in 1% of normal sera. Anti-HMG1 and anti-HMG2 occurred at frequencies of 30% and 35% respectively in PBC. Serum levels of anti-SOX13 and anti-HMG correlated significantly for PBC although not for Type 1 diabetes. Anti-SOX13 in PBC may occur merely as an immune response to products of damage to parenchymal tissue, or may be illustrative of a general proclivity of transcriptional regulatory proteins to elicit autoimmune responses. (C) 2002 Elsevier Science Ltd. All rights reserved.